VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1563042
Sex: F
Age: 83
State: TN

Vax Date: 02/23/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DYSGEUSIA (Metallic taste). At the time of the report, DYSGEUSIA (Metallic taste) outcome was unknown. No concomitant medications were reported. No treatment medication was reported. Patient gave consent to be followed up by safety.

Other Meds:

Current Illness:

ID: 1563043
Sex: F
Age:
State: SC

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itching). At the time of the report, VACCINATION SITE PRURITUS (Injection site itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. No concomitant medication was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1563044
Sex: M
Age: 69
State: TX

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: patient can't get his second dose yet, received first dose 6 weeks ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient can't get his second dose yet, received first dose 6 weeks ago) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for an unknown indication. No Medical History information was reported. On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient can't get his second dose yet, received first dose 6 weeks ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient can't get his second dose yet, received first dose 6 weeks ago) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medication was reported. Patient gave his consent for safety to Follow-up

Other Meds:

Current Illness:

ID: 1563045
Sex: F
Age: 61
State: LA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: difficulty breathing for about 2 minutes; couldn't function; couldn?t think straight; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing for about 2 minutes), ABNORMAL BEHAVIOUR (couldn't function) and THINKING ABNORMAL (couldn?t think straight) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0BA21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DYSPNOEA (difficulty breathing for about 2 minutes), ABNORMAL BEHAVIOUR (couldn't function) and THINKING ABNORMAL (couldn?t think straight). At the time of the report, DYSPNOEA (difficulty breathing for about 2 minutes), ABNORMAL BEHAVIOUR (couldn't function) and THINKING ABNORMAL (couldn?t think straight) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow-up received contains non-significant information of reporter details.

Other Meds:

Current Illness:

ID: 1563046
Sex: F
Age: 71
State: NJ

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Headache; Slight fever/ low grade fever; Nausea/ nauseated; Tiredness/ so tired; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Slight fever/ low grade fever), NAUSEA (Nausea/ nauseated) and FATIGUE (Tiredness/ so tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included FAMOTIDINE, ESZOPICLONE (LUNESTA), IBUPROFEN and REPAGLINIDE (PRANDIN [REPAGLINIDE]) for an unknown indication. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (Headache), PYREXIA (Slight fever/ low grade fever), NAUSEA (Nausea/ nauseated) and FATIGUE (Tiredness/ so tired). At the time of the report, HEADACHE (Headache), PYREXIA (Slight fever/ low grade fever), NAUSEA (Nausea/ nauseated) and FATIGUE (Tiredness/ so tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow-up received on 30-APR-2021 included: Patient declined further follow-up.

Other Meds: FAMOTIDINE; LUNESTA; IBUPROFEN; PRANDIN [REPAGLINIDE]

Current Illness:

ID: 1563047
Sex: M
Age: 76
State: FL

Vax Date: 03/04/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were reported. No Treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Vaccine Start date updated.

Other Meds:

Current Illness:

ID: 1563048
Sex: M
Age: 74
State: NV

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: He got 1ml dose instead of 0.5ml; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (He got 1ml dose instead of 0.5ml) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. No medical history was reported. Concomitant products included LORAZEPAM (ATIVAN) for an unknown indication. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (He got 1ml dose instead of 0.5ml). At the time of the report, ACCIDENTAL OVERDOSE (He got 1ml dose instead of 0.5ml) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication was reported. Patient gave consent for safety to Follow-up.

Other Meds: ATIVAN

Current Illness:

ID: 1563049
Sex: F
Age:
State: PR

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Mild itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Mild itchiness at injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (Mild itchiness at injection site). At the time of the report, INJECTION SITE PRURITUS (Mild itchiness at injection site) outcome was unknown. No concomitant medications were provided. No treatment medication was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1563050
Sex: F
Age: 69
State: IL

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: felt weak; fever; muscle aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (felt weak), PYREXIA (fever), MYALGIA (muscle aches) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ASTHENIA (felt weak), PYREXIA (fever), MYALGIA (muscle aches) and CHILLS (Chills). On 04-Mar-2021, ASTHENIA (felt weak), PYREXIA (fever), MYALGIA (muscle aches) and CHILLS (Chills) had resolved. Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided. This case was linked to MOD21-045015 (Patient Link).

Other Meds:

Current Illness:

ID: 1563051
Sex: M
Age: 68
State: NJ

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: did not get second dose within vaccine schedule window; Slack hives and pimple puscle like/systemic rash and hives from his neck to buttock and around his waist and arms/red, itchy, raised, and large hives; Slack hives and pimple puscle; Red, itchy, raised, and large hives; Red, itchy, raised, and large hives; Red, itchy, raised, and large hives; 2 types of rash in his back to buttocks area/systemic rash and hives from his neck to buttock and around his waist and arms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Slack hives and pimple puscle like/systemic rash and hives from his neck to buttock and around his waist and arms/red, itchy, raised, and large hives), ACNE (Slack hives and pimple puscle), URTICARIA PAPULAR (Red, itchy, raised, and large hives), PRURITUS (Red, itchy, raised, and large hives) and ERYTHEMA (Red, itchy, raised, and large hives) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Hay fever. Concurrent medical conditions included Asthma, COPD, Bee sting hypersensitivity (Itching , swelling and sob), Hypersensitivity and Arthritis. Concomitant products included UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (ANORO ELLIPTA) and FLUTICASONE PROPIONATE (PROAIR [FLUTICASONE PROPIONATE]) for COPD. On 26-Feb-2021 at 1:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced URTICARIA (Slack hives and pimple puscle like/systemic rash and hives from his neck to buttock and around his waist and arms/red, itchy, raised, and large hives), ACNE (Slack hives and pimple puscle), URTICARIA PAPULAR (Red, itchy, raised, and large hives), PRURITUS (Red, itchy, raised, and large hives), ERYTHEMA (Red, itchy, raised, and large hives) and RASH (2 types of rash in his back to buttocks area/systemic rash and hives from his neck to buttock and around his waist and arms). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not get second dose within vaccine schedule window). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) on 28-Feb-2021 at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 28-Feb-2021 at a dose of 50 mg. At the time of the report, URTICARIA (Slack hives and pimple puscle like/systemic rash and hives from his neck to buttock and around his waist and arms/red, itchy, raised, and large hives), ACNE (Slack hives and pimple puscle), URTICARIA PAPULAR (Red, itchy, raised, and large hives), PRURITUS (Red, itchy, raised, and large hives), ERYTHEMA (Red, itchy, raised, and large hives) and RASH (2 types of rash in his back to buttocks area/systemic rash and hives from his neck to buttock and around his waist and arms) had not resolved and PRODUCT DOSE OMISSION ISSUE (did not get second dose within vaccine schedule window) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications Annora Ellipta, Proair. Treatment : Zyrtec, Benadryl Patient no longer taking the treatment medications. Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Non significant follow up- Event Addition and source document attachment

Other Meds: ANORO ELLIPTA; PROAIR [FLUTICASONE PROPIONATE]

Current Illness: Arthritis; Asthma; Bee sting hypersensitivity (Itching , swelling and sob); COPD; Hypersensitivity

ID: 1563052
Sex: F
Age: 67
State: IL

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: lightheaded/dizzy; has ache in the right arm; loss in appetite; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded/dizzy), PAIN IN EXTREMITY (has ache in the right arm) and DECREASED APPETITE (loss in appetite) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. Concurrent medical conditions included Vertigo. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (lightheaded/dizzy), PAIN IN EXTREMITY (has ache in the right arm) and DECREASED APPETITE (loss in appetite). At the time of the report, DIZZINESS (lightheaded/dizzy), PAIN IN EXTREMITY (has ache in the right arm) and DECREASED APPETITE (loss in appetite) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: She doesn't have an email address. She stated she is fine now and had both shots.

Other Meds:

Current Illness: Vertigo

ID: 1563053
Sex: F
Age:
State:

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Cold; Bloody shot eye; Burning sensation underneath her eyes; General body pain; Jaw ache; Chills; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold), OCULAR HYPERAEMIA (Bloody shot eye), EYE IRRITATION (Burning sensation underneath her eyes), PAIN (General body pain) and PAIN IN JAW (Jaw ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold), OCULAR HYPERAEMIA (Bloody shot eye), EYE IRRITATION (Burning sensation underneath her eyes), PAIN (General body pain), PAIN IN JAW (Jaw ache), CHILLS (Chills) and FATIGUE (Exhausted). At the time of the report, NASOPHARYNGITIS (Cold), OCULAR HYPERAEMIA (Bloody shot eye), EYE IRRITATION (Burning sensation underneath her eyes), PAIN (General body pain), PAIN IN JAW (Jaw ache), CHILLS (Chills) and FATIGUE (Exhausted) outcome was unknown. Treatment Medications and Concomitant Medications were not provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-JUNE-2021 and does not contain any new information

Other Meds:

Current Illness:

ID: 1563054
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm). At the time of the report, PAIN IN EXTREMITY (pain in the arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medications reported. No treatment medications were provided

Other Meds:

Current Illness:

ID: 1563055
Sex: F
Age: 84
State: VA

Vax Date: 02/24/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: hive like apperance/circumference is 3 and a quarter inches; itchy; redness; swelling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE URTICARIA (hive like apperance/circumference is 3 and a quarter inches), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (redness) and SWELLING (swelling) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The patient's past medical history included Aortic valve replacement in 2020. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), RAMIPRIL, GABAPENTIN, LEVOTHYROXINE, VITAMIN D NOS and BIFIDOBACTERIUM INFANTIS (ALIGN) for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (hive like apperance/circumference is 3 and a quarter inches), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (redness) and SWELLING (swelling). At the time of the report, VACCINATION SITE URTICARIA (hive like apperance/circumference is 3 and a quarter inches), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (redness) and SWELLING (swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications also included unspecified allergy shots taken once a week. Treatment included loratadine and topical diphenhydramine. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: ASPIRIN 81; RAMIPRIL; GABAPENTIN; LEVOTHYROXINE; VITAMIN D NOS; ALIGN

Current Illness:

ID: 1563056
Sex: F
Age: 59
State: CA

Vax Date: 02/10/2021
Onset Date: 02/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Headache; Loss Of Taste; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) and AGEUSIA (Loss Of Taste) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history was provided). On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HEADACHE (Headache) and AGEUSIA (Loss Of Taste). At the time of the report, HEADACHE (Headache) and AGEUSIA (Loss Of Taste) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1563057
Sex: F
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: just a sore arm; headache; Was not bothered much; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (just a sore arm), HEADACHE (headache) and ADVERSE EVENT (Was not bothered much) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Headache. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (just a sore arm), HEADACHE (headache) and ADVERSE EVENT (Was not bothered much). At the time of the report, PAIN IN EXTREMITY (just a sore arm), HEADACHE (headache) and ADVERSE EVENT (Was not bothered much) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1563058
Sex: F
Age: 54
State: TN

Vax Date: 01/04/2021
Onset Date: 02/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: ear pain above my ear on my head/ear pain; ear infection in both ears but left is worse; fever of 101.2; body aches; This spontaneous case was reported by a nurse and describes the occurrence of EAR PAIN (ear pain above my ear on my head/ear pain), EAR INFECTION (ear infection in both ears but left is worse), PYREXIA (fever of 101.2) and MYALGIA (body aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No relevant concomitant medications reported No relevant medical history was reported. On 04-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 05-Feb-2021, the patient experienced PYREXIA (fever of 101.2) and MYALGIA (body aches). On 07-Feb-2021, the patient experienced EAR PAIN (ear pain above my ear on my head/ear pain). 07-Feb-2021, the patient experienced EAR INFECTION (ear infection in both ears but left is worse). On 06-Feb-2021, PYREXIA (fever of 101.2) and MYALGIA (body aches) had resolved. At the time of the report, EAR PAIN (ear pain above my ear on my head/ear pain) and EAR INFECTION (ear infection in both ears but left is worse) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. She states that the infection is in both ears but the left ear is worse. She has had to go through 3 rounds of antibiotics which have not helped heal the infection so far. She is currently on the 3rd round of antibiotics. Her HCP has also referred her to an ENT for further guidance. Treatment medication she took included Amoxicillin, Omnicef

Other Meds:

Current Illness:

ID: 1563059
Sex: F
Age: 69
State: FL

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Her right foot is still hard, it goes numb; Her right foot is still hard, it goes numb; Feels like it weights a hundred pounds; foot still hurts; Couldn't move the right Hip and below; Itchiness; Red patches; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb), LIMB DISCOMFORT (Feels like it weights a hundred pounds), PAIN IN EXTREMITY (Arm pain) and PRURITUS (Itchiness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Thyroiditis. Concomitant products included AMLODIPINE, ATORVASTATIN, VITAMINS NOS, OXYBUTYNIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and OMEPRAZOLE for an unknown indication. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 16-Feb-2021, the patient experienced PRURITUS (Itchiness) and ERYTHEMA (Red patches). On 18-Feb-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (Couldn't move the right Hip and below). In March 2021, the patient experienced HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb), LIMB DISCOMFORT (Feels like it weights a hundred pounds) and PAIN IN EXTREMITY (foot still hurts). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. At the time of the report, HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb) and LIMB DISCOMFORT (Feels like it weights a hundred pounds) outcome was unknown, PAIN IN EXTREMITY (Arm pain), PRURITUS (Itchiness), ERYTHEMA (Red patches) and MUSCULOSKELETAL DISCOMFORT (Couldn't move the right Hip and below) was resolving and PAIN IN EXTREMITY (foot still hurts) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Computerised tomogram: (normal) Normal. In March 2021, Computerised tomogram: (normal) CT scan was clear.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication also included an unspecified thyroid medication. Treatment for the events included topical cream and unknown pills. Most recent FOLLOW-UP information incorporated above includes: On 04-Mar-2021: New event right foot is still hard, it goes numb and feels like it weights a hundred pounds were reported. New lab test CT scan was reported. On 09-Jul-2021: Event added.

Other Meds: AMLODIPINE; ATORVASTATIN; VITAMINS NOS; OXYBUTYNIN; ASPIRIN (E.C.); OMEPRAZOLE

Current Illness: Thyroiditis

ID: 1563060
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Loss of taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Loss of taste). At the time of the report, AGEUSIA (Loss of taste) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1563061
Sex: F
Age:
State: CA

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: chills; slight nausea; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), NAUSEA (slight nausea) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No relevant concomitant medications reported No relevant medical history was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PYREXIA (fever), NAUSEA (slight nausea) and HEADACHE (headache). On an unknown date, the patient experienced CHILLS (chills). On 27-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, CHILLS (chills) had resolved and NAUSEA (slight nausea) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment Medications were not provided by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1563062
Sex: F
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Received her first vaccine and then contracted with Covid 19; A spontaneous report was received from a consumer concerning a female patient of an unknown age who received first dose of Moderna's COVID-19 vaccine (mRNA-1273) and contracted with COVID-19. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, after receiving first vaccine and the patient contracted with COVID-19. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event contracted with COVID-19 was not reported.; Sender's Comments: COVID-19 in this patient is unlikely to be due to the Moderna COVID-19 vaccine

Other Meds:

Current Illness:

ID: 1563063
Sex: F
Age: 82
State: GA

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: arm soreness; back aches; chills; headache; fever 101.3; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), BACK PAIN (back aches), CHILLS (chills) and PYREXIA (fever 101.3) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No relevant medical history was reported. Concomitant products included ALBUTEROL [SALBUTAMOL], VITAMIN B12 [VITAMIN B12 NOS] and VITAMIN D3 for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), BACK PAIN (back aches), CHILLS (chills) and PYREXIA (fever 101.3). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. On 19-Feb-2021, PAIN IN EXTREMITY (arm soreness) and BACK PAIN (back aches) had resolved. At the time of the report, CHILLS (chills) and PYREXIA (fever 101.3) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: ALBUTEROL [SALBUTAMOL]; VITAMIN B12 [VITAMIN B12 NOS]; VITAMIN D3

Current Illness:

ID: 1563064
Sex: F
Age: 64
State: AZ

Vax Date: 03/06/2021
Onset Date: 03/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Low grade fever; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever), CHILLS (Chills) and PAIN (Body aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes mellitus, Neuropathy, Cholesterol and Sleep disorder. Concomitant products included ATORVASTATIN for Cholesterol, INSULIN DETEMIR (LEVEMIR) and SITAGLIPTIN (JANUVIA [SITAGLIPTIN]) for Diabetes mellitus, GABAPENTIN for Neuropathy, ALPRAZOLAM (XANAX) for an unknown indication. On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PYREXIA (Low grade fever), CHILLS (Chills) and PAIN (Body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Low grade fever), CHILLS (Chills) and PAIN (Body aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was reported.

Other Meds: LEVEMIR; JANUVIA [SITAGLIPTIN]; GABAPENTIN; ATORVASTATIN; XANAX

Current Illness: Cholesterol; Diabetes mellitus; Neuropathy; Sleep disorder

ID: 1563065
Sex: F
Age: 97
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: experiencing her aging signs increasing; feeling dizzier; feeling weaker; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (experiencing her aging signs increasing), DIZZINESS (feeling dizzier) and ASTHENIA (feeling weaker) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced ADVERSE EVENT (experiencing her aging signs increasing), DIZZINESS (feeling dizzier) and ASTHENIA (feeling weaker). At the time of the report, ADVERSE EVENT (experiencing her aging signs increasing), DIZZINESS (feeling dizzier) and ASTHENIA (feeling weaker) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1563066
Sex: M
Age: 69
State: OH

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Rash in chest / rash at the back / rash in both arms; Redness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in chest / rash at the back / rash in both arms) and ERYTHEMA (Redness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. Concurrent medical conditions included Cholesterol, Hypertension and Anxiety. Concomitant products included MIRTAZAPINE for Anxiety, SIMVASTATIN for Cholesterol, AMLODIPINE for Hypertension, GABAPENTIN for an unknown indication. On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced RASH (Rash in chest / rash at the back / rash in both arms) and ERYTHEMA (Redness). At the time of the report, RASH (Rash in chest / rash at the back / rash in both arms) and ERYTHEMA (Redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment Medications were not provided by the reporter.

Other Meds: GABAPENTIN; SIMVASTATIN; AMLODIPINE; MIRTAZAPINE

Current Illness: Anxiety; Cholesterol; Hypertension

ID: 1563067
Sex: F
Age: 78
State: NC

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: I felt like I got sicker the more I laid down; feel like I have the flu; I threw up all the water I had; can't eat anything because of the nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I felt like I got sicker the more I laid down), INFLUENZA LIKE ILLNESS (feel like I have the flu), VOMITING (I threw up all the water I had) and NAUSEA (can't eat anything because of the nausea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (being positive) in December 2020. Concomitant products included PIOGLITAZONE HYDROCHLORIDE (ACTOS), FUROSEMIDE, LEVOTHYROXINE, LOSARTAN, CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]), OMEPRAZOLE, ACETYLSALICYLIC ACID (BABY ASPIRIN), SERTRALINE, TICAGRELOR (BRILINTA), VITAMIN D3 and REPAGLINIDE (PRANDIN [REPAGLINIDE]) for an unknown indication. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ILLNESS (I felt like I got sicker the more I laid down), INFLUENZA LIKE ILLNESS (feel like I have the flu), VOMITING (I threw up all the water I had) and NAUSEA (can't eat anything because of the nausea). At the time of the report, ILLNESS (I felt like I got sicker the more I laid down), INFLUENZA LIKE ILLNESS (feel like I have the flu), VOMITING (I threw up all the water I had) and NAUSEA (can't eat anything because of the nausea) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided.

Other Meds: ACTOS; FUROSEMIDE; LEVOTHYROXINE; LOSARTAN; MACROBID [CLARITHROMYCIN]; OMEPRAZOLE; BABY ASPIRIN; SERTRALINE; BRILINTA; VITAMIN D3; PRANDIN [REPAGLINIDE]

Current Illness:

ID: 1563068
Sex: F
Age: 56
State: MI

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: I can't think; Serious headache; Fever / It went from 100 - 101, and the top it reached was 102.4; This spontaneous case was reported by a consumer and describes the occurrence of THINKING ABNORMAL (I can't think), PYREXIA (Fever / It went from 100 - 101, and the top it reached was 102.4) and HEADACHE (Serious headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. Concurrent medical conditions included Seizure and Arthritis. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Fever / It went from 100 - 101, and the top it reached was 102.4). On an unknown date, the patient experienced THINKING ABNORMAL (I can't think) and HEADACHE (Serious headache). At the time of the report, THINKING ABNORMAL (I can't think), PYREXIA (Fever / It went from 100 - 101, and the top it reached was 102.4) and HEADACHE (Serious headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. concomitant medicines include seizure and arthritis medicines . Treatment Medications were not provided by the reporter.

Other Meds:

Current Illness: Arthritis; Seizure

ID: 1563069
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Breasts were severely sore; Under the arm very sore; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Breasts were severely sore) and AXILLARY PAIN (Under the arm very sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (Breasts were severely sore) and AXILLARY PAIN (Under the arm very sore). At the time of the report, BREAST PAIN (Breasts were severely sore) and AXILLARY PAIN (Under the arm very sore) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: other (Inconclusive) Patient had a mammogram after the first shot.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1563070
Sex: F
Age: 66
State: AZ

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: edema on my legs; 6 inch long and 2 inch wide patch of pink rash/ rash on my back/rash on my legs; sore; 2 little circles around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore), VACCINATION SITE REACTION (2 little circles around the injection site), RASH (6 inch long and 2 inch wide patch of pink rash/ rash on my back/rash on my legs) and OEDEMA PERIPHERAL (edema on my legs) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore) and VACCINATION SITE REACTION (2 little circles around the injection site). On 22-Feb-2021, the patient experienced RASH (6 inch long and 2 inch wide patch of pink rash/ rash on my back/rash on my legs). On 02-Mar-2021, the patient experienced OEDEMA PERIPHERAL (edema on my legs). At the time of the report, PAIN IN EXTREMITY (sore), RASH (6 inch long and 2 inch wide patch of pink rash/ rash on my back/rash on my legs) and OEDEMA PERIPHERAL (edema on my legs) outcome was unknown and VACCINATION SITE REACTION (2 little circles around the injection site) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1563071
Sex: M
Age:
State: CA

Vax Date: 02/25/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Chills; Diarrhea; fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), DIARRHOEA (Diarrhea), PYREXIA (fever) and FATIGUE (Fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced CHILLS (Chills), DIARRHOEA (Diarrhea), PYREXIA (fever) and FATIGUE (Fatigue). At the time of the report, CHILLS (Chills), DIARRHOEA (Diarrhea), PYREXIA (fever) and FATIGUE (Fatigue) outcome was unknown. Not Provided Concomitant medications were not provided. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1563072
Sex: F
Age: 108
State: NJ

Vax Date: 02/15/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Tested positive for COVID-19; Feels like a cough in her head; Feels a bit bad; Loss of smell; Cough; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19), HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell) and COUGH (Cough) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell), COUGH (Cough) and HEADACHE (Headache). On 26-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19), HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell), COUGH (Cough) and HEADACHE (Headache) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient's concomitant medications were not reported. The patient reported that her COVID symptoms were really mild and never needed oxygen or felt too bad. The patient stated that the only thing that bothered her was having no sense of smell for about a week. The patient felt completely well at the time of this report. No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Outcome of the events were changed from Unknown to recovered.

Other Meds:

Current Illness:

ID: 1563073
Sex: F
Age:
State: FL

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain is going up the neck) and VACCINATION SITE PAIN (Her left arm started hurting like devil) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The patient's past medical history included Mastectomy (Had a Mastectomy 40years ago). On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 03-Mar-2021, the patient experienced NECK PAIN (Pain is going up the neck) and VACCINATION SITE PAIN (Her left arm started hurting like devil). At the time of the report, NECK PAIN (Pain is going up the neck) and VACCINATION SITE PAIN (Her left arm started hurting like devil) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1563074
Sex: M
Age:
State: CT

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: arm soreness; Local redness "2-3 inches below injection site and about 6 inches wide"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide") in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide"). At the time of the report, PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide") outcome was unknown. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1563075
Sex: F
Age: 66
State:

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: a very strong headache/a generalized headache, in all the head; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (a very strong headache/a generalized headache, in all the head) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024W20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concurrent medical conditions included Hypertension, Diabetes and Cholesterol. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEADACHE (a very strong headache/a generalized headache, in all the head). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (a very strong headache/a generalized headache, in all the head) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: (Inconclusive) normal. On an unknown date, Oxygen saturation: % (Inconclusive) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications for blood pressure, cholesterol, stomach, diabetes and for sleep. (Information not provided)

Other Meds:

Current Illness: Cholesterol; Diabetes; Hypertension

ID: 1563076
Sex: F
Age:
State:

Vax Date: 03/02/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: annoying; little rash; itchy; (rash) is even in my scalp; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE IRRITATION (annoying), INJECTION SITE RASH (little rash), INJECTION SITE PRURITUS (itchy) and RASH ((rash) is even in my scalp) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE IRRITATION (annoying), INJECTION SITE RASH (little rash), INJECTION SITE PRURITUS (itchy) and RASH ((rash) is even in my scalp). At the time of the report, INJECTION SITE IRRITATION (annoying), INJECTION SITE RASH (little rash), INJECTION SITE PRURITUS (itchy) and RASH ((rash) is even in my scalp) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication details were not provided. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1563077
Sex: M
Age:
State:

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Body Aches; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body Aches) and VACCINATION SITE PAIN (Soreness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced MYALGIA (Body Aches) and VACCINATION SITE PAIN (Soreness). At the time of the report, MYALGIA (Body Aches) and VACCINATION SITE PAIN (Soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No laboratory details were provided. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1563078
Sex: M
Age: 66
State: NC

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: artificial joints in my neck feeling very stiff; feel tired; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (artificial joints in my neck feeling very stiff) and FATIGUE (feel tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The patient's past medical history included Joint arthroplasty (due to an accident years ago). On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (artificial joints in my neck feeling very stiff) and FATIGUE (feel tired). At the time of the report, MUSCULOSKELETAL STIFFNESS (artificial joints in my neck feeling very stiff) and FATIGUE (feel tired) was resolving. No concomitant information was provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: event start date added, outcome updated from unknown to recovering

Other Meds:

Current Illness:

ID: 1563079
Sex: M
Age: 83
State: WA

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Neck pain is getting worse; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain is getting worse) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 immunisation. No medical history was provided by the reporter. On 05-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced NECK PAIN (Neck pain is getting worse). At the time of the report, NECK PAIN (Neck pain is getting worse) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1563080
Sex: M
Age:
State:

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Original vaccine administration site no longer had Moderna available for patient's second dose; Missed dose; A spontaneous report was received from a consumer, concerning her husband, a male patient of unspecified age, who received Moderna's COVID-19 vaccine (mRNA-1273) and original vaccine administration site no longer had Moderna available for patient's second dose/ product availability issue and missed dose. The patient's medical history was not provided. No relevant concomitant medications were reported. On 26 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. On 26 Jan 2021, patient's original vaccine administration site no longer had Moderna available for patient's second dose and several other clinics had also refused the vaccine to patient as patient did not obtain his first dose at their facility. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not reported. The outcome of events original vaccine administration site no longer had Moderna available for patient's second dose and missed dose were considered unknown at the time of this report.; Reporter's Comments: This report refers to a male patient of unspecified age who experienced non-serious unexpected event of original vaccine administration site no longer had Moderna available for patient's second dose/ (product availability issue and missed dose). There were no reported AEs associated with this case of product availability issue and missed dose.

Other Meds:

Current Illness:

ID: 1563081
Sex: M
Age:
State: CA

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Felt cold; Sinuses were messed up; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Felt cold), SINUS DISORDER (Sinuses were messed up) and PAIN (Body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced NASOPHARYNGITIS (Felt cold), SINUS DISORDER (Sinuses were messed up) and PAIN (Body aches). At the time of the report, NASOPHARYNGITIS (Felt cold), SINUS DISORDER (Sinuses were messed up) and PAIN (Body aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was reported. Treatment medication was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1563082
Sex: F
Age: 68
State: MA

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: generalized rash that she got after she had the Moderna shot on day 8-9; Back was itching; fatigue; vaccination site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Back was itching), VACCINATION SITE PAIN (vaccination site tenderness), RASH (generalized rash that she got after she had the Moderna shot on day 8-9) and FATIGUE (fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (allergic to doxycycline). On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (vaccination site tenderness). On 19-Feb-2021, the patient experienced FATIGUE (fatigue). On 26-Feb-2021, the patient experienced PRURITUS (Back was itching). On an unknown date, the patient experienced RASH (generalized rash that she got after she had the Moderna shot on day 8-9). On 19-Feb-2021, FATIGUE (fatigue) had resolved. On 20-Feb-2021, VACCINATION SITE PAIN (vaccination site tenderness) had resolved. On 05-Mar-2021, PRURITUS (Back was itching) had resolved. At the time of the report, RASH (generalized rash that she got after she had the Moderna shot on day 8-9) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. patient had bath and body brand lotion and Zyrtec as treatment medication. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: NNI

Other Meds:

Current Illness: Drug allergy (allergic to doxycycline)

ID: 1563083
Sex: F
Age: 67
State: PA

Vax Date: 03/02/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Big circle at the site of injection; Warm to the touch circle at the site of injection; Red circle at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of ADMINISTRATION SITE INDENTATION (Big circle at the site of injection), VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection) and VACCINATION SITE ERYTHEMA (Red circle at the site of injection) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced ADMINISTRATION SITE INDENTATION (Big circle at the site of injection), VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection) and VACCINATION SITE ERYTHEMA (Red circle at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ADMINISTRATION SITE INDENTATION (Big circle at the site of injection), VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection) and VACCINATION SITE ERYTHEMA (Red circle at the site of injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1563084
Sex: F
Age: 54
State: NY

Vax Date: 03/03/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Sore arm; large blisters; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and BLISTER (large blisters) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and BLISTER (large blisters). At the time of the report, PAIN IN EXTREMITY (Sore arm) and BLISTER (large blisters) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported. No treatment information provided.

Other Meds:

Current Illness:

ID: 1563085
Sex: F
Age: 74
State: GA

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 002A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported adverse event). On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swollen arm). At the time of the report, VACCINATION SITE SWELLING (swollen arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1563086
Sex: F
Age: 56
State: MN

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Lot of anxiety; Very teary; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Lot of anxiety) and TEARFULNESS (Very teary) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010a21a) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ANXIETY (Lot of anxiety) and TEARFULNESS (Very teary). At the time of the report, ANXIETY (Lot of anxiety) and TEARFULNESS (Very teary) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds: LEXAPRO

Current Illness:

ID: 1563087
Sex: F
Age: 71
State: AZ

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: itchy; hives; redness; rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), URTICARIA (hives), ERYTHEMA (redness) and RASH (rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchy), URTICARIA (hives), ERYTHEMA (redness) and RASH (rash). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) at an unspecified dose and frequency. At the time of the report, PRURITUS (itchy), URTICARIA (hives), ERYTHEMA (redness) and RASH (rash) outcome was unknown. The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable. Treatment details included Tylenol, antihistamine.

Other Meds:

Current Illness:

ID: 1563088
Sex: F
Age: 81
State: NJ

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: severe diarrhea; burn sensation from insertion of needle; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burn sensation from insertion of needle) and DIARRHOEA (severe diarrhea) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. Concurrent medical conditions included Rheumatoid arthritis, Food allergy (Mushroom) and Drug allergy (Amoxicillin). Concomitant products included ADALIMUMAB (HUMIRA) for Immunosuppressant drug therapy, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ) and METOPROLOL for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced BURNING SENSATION (burn sensation from insertion of needle). On 22-Feb-2021, the patient experienced DIARRHOEA (severe diarrhea). On 12-Feb-2021, BURNING SENSATION (burn sensation from insertion of needle) had resolved. At the time of the report, DIARRHOEA (severe diarrhea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: HUMIRA; LOSARTAN/HCTZ; METOPROLOL; SYNTHROID

Current Illness: Drug allergy (Amoxicillin); Food allergy (Mushroom); Rheumatoid arthritis

ID: 1563089
Sex: M
Age:
State:

Vax Date: 03/02/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Having an adverse reaction which deals with his eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (Having an adverse reaction which deals with his eyes) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE DISORDER (Having an adverse reaction which deals with his eyes). At the time of the report, EYE DISORDER (Having an adverse reaction which deals with his eyes) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported. No treatment information provided.

Other Meds:

Current Illness:

ID: 1563090
Sex: F
Age: 66
State: CA

Vax Date: 01/20/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: lips are so dry; Red; rash in her face, around their teeth, nose and forehead; This spontaneous case was reported by a consumer and describes the occurrence of LIP DRY (lips are so dry), ERYTHEMA (Red) and RASH (rash in her face, around their teeth, nose and forehead) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021L20A and 013M20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced RASH (rash in her face, around their teeth, nose and forehead). On an unknown date, the patient experienced LIP DRY (lips are so dry) and ERYTHEMA (Red). At the time of the report, LIP DRY (lips are so dry), ERYTHEMA (Red) and RASH (rash in her face, around their teeth, nose and forehead) had not resolved. Concomitant medication included unspecified high blood pressure medication. No treatment information was provided. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1563091
Sex: F
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: bump is firm; pain in shoulder; has a pretty big bump at the site of injection; bump is red; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE INDURATION (bump is firm), ARTHRALGIA (pain in shoulder), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE INDURATION (bump is firm), ARTHRALGIA (pain in shoulder), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red). On 04-Mar-2021, ARTHRALGIA (pain in shoulder) had resolved. At the time of the report, VACCINATION SITE INDURATION (bump is firm), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm